Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

909
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
909
Colloidal precipitates01:09

Colloidal precipitates

759
The high insolubility of some precipitates can result in an unfavorable relative supersaturation. This can lead to colloidal particles with a large surface-to-mass ratio, where adsorption is promoted. For instance, in the precipitation of silver chloride, silver ions are adsorbed on the surface of the colloidal particles, forming a primary layer. This layer attracts ions of opposite charge (such as nitrate ions), forming a diffuse secondary layer of adsorbed ions. This electric double layer...
759
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants01:18

Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants

1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

645
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
645
Coagulation01:06

Coagulation

374
Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
374

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Electrochemomics Profiling Metabolic Dynamics in Biofluids.

Journal of the American Chemical Society·2026
Same author

Dynamic Protonation on an Amino-Containing Quinone-Covalent Organic Framework Enables Efficient Neutral Electrosynthesis of H<sub>2</sub>O<sub>2</sub>.

Angewandte Chemie (International ed. in English)·2026
Same author

Symmetry breaking of single-atom catalysts in heterogeneous electrocatalysis: reactivity and configuration.

Chemical Society reviews·2025
Same author

High Rate of Cytokine Release Syndrome-Related Coagulopathy with Low Incidence of Bleeding and Thrombosis in Patients Treated with B-Cell Maturation Antigen (BCMA)-Targeted Chimeric Antigen Receptor T-Cells (CAR-T).

Cancers·2025
Same author

Von Willebrand factor and JAK2V617F variant allele frequency predict thrombosis and bleeding in patients with myeloproliferative neoplasms.

Annals of hematology·2025
Same author

Suppression of Halide Ion Crossover in Zn-Halide Batteries by 2D MXene Membranes.

ACS applied materials & interfaces·2025

Related Experiment Video

Updated: Sep 12, 2025

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

510

Establishing the Principles for Antithrombogenic Coatings Based on Sol-Gel Films.

Yebin Byun1, Ela Shai2, Yosef Kalish2

  • 1Institute of Chemistry and The Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Jerusalem 9190401, Israel.

Langmuir : the ACS Journal of Surfaces and Colloids
|August 7, 2025
PubMed
Summary

This study developed a robust, hydrophilic coating using sol-gel technology to prevent blood clot formation on medical devices. The advanced coating significantly reduces protein and platelet adhesion, crucial for preventing thrombosis.

More Related Videos

Graphene Coatings for Biomedical Implants
13:21

Graphene Coatings for Biomedical Implants

Published on: March 1, 2013

21.4K
Fabrication of Superhydrophobic Metal Surfaces for Anti-Icing Applications
11:20

Fabrication of Superhydrophobic Metal Surfaces for Anti-Icing Applications

Published on: August 15, 2018

8.7K

Related Experiment Videos

Last Updated: Sep 12, 2025

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting
08:53

Artificial Lung Device Priming for In Situ Fiber Bundle Surface Grafting

Published on: March 28, 2025

510
Graphene Coatings for Biomedical Implants
13:21

Graphene Coatings for Biomedical Implants

Published on: March 1, 2013

21.4K
Fabrication of Superhydrophobic Metal Surfaces for Anti-Icing Applications
11:20

Fabrication of Superhydrophobic Metal Surfaces for Anti-Icing Applications

Published on: August 15, 2018

8.7K

Area of Science:

  • Biomaterials Science
  • Surface Chemistry
  • Medical Device Technology

Background:

  • Medical devices in contact with blood pose a risk of thrombosis, or blood clot formation.
  • Antithrombogenic coatings are essential to prevent adverse blood clot formation on implanted devices.
  • Current strategies require improved methods to inhibit the initial stages of coagulation.

Purpose of the Study:

  • To develop and evaluate a novel antithrombogenic coating using sol-gel technology.
  • To investigate the relationship between surface wettability and antithrombogenic properties.
  • To prevent protein adhesion, the initial step in clot formation, on medical device surfaces.

Main Methods:

  • Utilized sol-gel technology to create a coating material.
  • Combined zwitterion precursor with tetraethyl orthosilicate.
  • Assessed surface wettability and protein adhesion.
  • Evaluated platelet adhesion to the coated surfaces.

Main Results:

  • Generated a robust and hydrophilic surface coating.
  • Demonstrated significant reduction in protein adhesion.
  • Showed a marked decrease in platelet adhesion to the surface.
  • Established a correlation between surface hydrophilicity and antithrombogenic efficacy.

Conclusions:

  • The developed sol-gel coating effectively prevents protein and platelet adhesion, key factors in thrombosis.
  • This hydrophilic coating shows promise for application on medical devices to enhance biocompatibility.
  • The findings support the use of this coating to mitigate thrombosis risk associated with blood-contacting implants.